BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $85 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $85.00 (from $97.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
